4//SEC Filing
Shah Preetam 4
Accession 0001610618-24-000009
CIK 0001610618other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 9:45 PM ET
Size
5.8 KB
Accession
0001610618-24-000009
Insider Transaction Report
Form 4
Shah Preetam
CFO & CBO
Transactions
- Sale
Common Stock
2024-03-11$0.67/sh−18,931$12,680→ 227,210 total
Footnotes (3)
- [F1]The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.66 to $0.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]Includes 8,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on May 19, 2023 and November 20, 2023.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001787403
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 9:45 PM ET
- Size
- 5.8 KB